Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Che A

15 indexed publications match this author name.

ORCID: 0000-0002-7530-8531
OpenAlex: https://openalex.org/A5039339381

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 7 Review Article 6 Safety 5 Addiction 4 Clinical Trial 4 Systematic Review 4 Neuroplasticity 4 Animal Study 4 Observational Study 4 Mechanism of Action 3 Adverse Events 3 Aging 3

Journals

bioRxiv: the preprint server for biology 2 Nature 2 Journal of psychopharmacology (Oxford, England) 1 Journal of clinical psychopharmacology 1 Nature communications 1 The journal of headache and pain 1 Neuroscience and biobehavioral reviews 1 Journal of psychoactive drugs 1

Publication history

Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.Journal of psychopharmacology (Oxford, England) · 2026-08-17 Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling.bioRxiv: the preprint server for biology · 2026-07-09 Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.Journal of clinical psychopharmacology · 2026-01-01 Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.Nature · 2025-10-01 Serotonin and psilocybin activate 5-HT receptors to suppress cortical signaling through the claustrum.Nature communications · 2025-08-19 Psilocybin's lasting action requires pyramidal cell types and 5-HT receptors.Nature · 2025-06-01 Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23 The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-05-01 Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-25 Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Progress in neuro-psychopharmacology & biological psychiatry · 2025-03-20 Pyramidal cell types and 5-HT receptors are essential for psilocybin's lasting drug action.bioRxiv: the preprint server for biology · 2024-11-03 A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?Psychedelic medicine (New Rochelle, N.Y.) · 2024-06-01 Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-05-01 A Review of Synthetic Access to Therapeutic Compounds Extracted from.Pharmaceuticals (Basel, Switzerland) · 2022-12-28 An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)ClinicalTrials.gov · 2022-10-12

Author directory